neovascular age-related macular degeneration(English)

• small interfering RNA technology-based therapies have been designed to downregulate the production of VEGF (bevasiranib) or VEGF receptors (AGN211745) by degradation of specific messenger RNA. Other potential therapies include pigment epithelium-derived factor-based therapies, nicotinic acetylcholine receptor antagonists, integrin antagonists and sirolimus
• CNV, AMD
• Ophthalmology, Therapeutic approaches
• https://doi.org…200868080-00002